539 related articles for article (PubMed ID: 24990999)
21. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.
Boyoglu-Barnum S; Todd SO; Chirkova T; Barnum TR; Gaston KA; Haynes LM; Tripp RA; Moore ML; Anderson LJ
Virology; 2015 Sep; 483():117-25. PubMed ID: 25965801
[TBL] [Abstract][Full Text] [Related]
22. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
Bian C; Liu S; Liu N; Zhang G; Xing L; Song Y; Duan Y; Gu H; Zhou Y; Zhang P; Li Z; Zhang K; Wang Z; Zhang S; Wang X; Yang P
Antiviral Res; 2014 Apr; 104():110-7. PubMed ID: 24509239
[TBL] [Abstract][Full Text] [Related]
23. Respiratory syncytial virus recombinant F protein (residues 255-278) induces a helper T cell type 1 immune response in mice.
Singh SR; Dennis VA; Carter CL; Pillai SR; Moore EG
Viral Immunol; 2007; 20(2):261-75. PubMed ID: 17603843
[TBL] [Abstract][Full Text] [Related]
24. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.
Bembridge GP; Lopez JA; Cook R; Melero JA; Taylor G
J Virol; 1998 May; 72(5):4080-7. PubMed ID: 9557697
[TBL] [Abstract][Full Text] [Related]
25. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
Olson MR; Hartwig SM; Varga SM
J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
[TBL] [Abstract][Full Text] [Related]
26. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
27. RSV fusion (F) protein DNA vaccine provides partial protection against viral infection.
Wu H; Dennis VA; Pillai SR; Singh SR
Virus Res; 2009 Oct; 145(1):39-47. PubMed ID: 19540885
[TBL] [Abstract][Full Text] [Related]
28. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice.
Caidi H; Harcourt JL; Tripp RA; Anderson LJ; Haynes LM
PLoS One; 2012; 7(12):e51485. PubMed ID: 23300550
[TBL] [Abstract][Full Text] [Related]
30. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
Haynes LM; Caidi H; Radu GU; Miao C; Harcourt JL; Tripp RA; Anderson LJ
J Infect Dis; 2009 Aug; 200(3):439-47. PubMed ID: 19545210
[TBL] [Abstract][Full Text] [Related]
32. Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.
Schijf MA; Kruijsen D; Bastiaans J; Coenjaerts FE; Garssen J; van Bleek GM; van't Land B
J Virol; 2012 Nov; 86(21):11472-82. PubMed ID: 22896622
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice.
Kamphuis T; Meijerhof T; Stegmann T; Lederhofer J; Wilschut J; de Haan A
PLoS One; 2012; 7(5):e36812. PubMed ID: 22590614
[TBL] [Abstract][Full Text] [Related]
34. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
35. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
Connors M; Kulkarni AB; Collins PL; Firestone CY; Holmes KL; Morse HC; Murphy BR
J Virol; 1992 Feb; 66(2):1277-81. PubMed ID: 1731105
[TBL] [Abstract][Full Text] [Related]
36. Assessing the protection elicited by virus-like particles expressing the RSV pre-fusion F and tandem repeated G proteins against RSV rA2 line19F infection in mice.
Kim MJ; Chu KB; Lee SH; Mao J; Eom GD; Yoon KW; Moon EK; Quan FS
Respir Res; 2024 Jan; 25(1):7. PubMed ID: 38178222
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide Inhibits FI-RSV Vaccine-enhanced Inflammation Through Regulating Th Responses.
Yin W; Li HY; Zheng BY; Deng YQ; Li WJ; Liu Y; Zeng RH
Curr Med Sci; 2019 Jun; 39(3):363-370. PubMed ID: 31209804
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.
Monick MM; Powers LS; Hassan I; Groskreutz D; Yarovinsky TO; Barrett CW; Castilow EM; Tifrea D; Varga SM; Hunninghake GW
J Immunol; 2007 Aug; 179(3):1648-58. PubMed ID: 17641031
[TBL] [Abstract][Full Text] [Related]
39. DNA vaccine encoding central conserved region of G protein induces Th1 predominant immune response and protection from RSV infection in mice.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zheng YP; Hong T; He JS
Immunol Lett; 2016 Nov; 179():95-101. PubMed ID: 27688078
[TBL] [Abstract][Full Text] [Related]
40. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
Dodd JS; Lum E; Goulding J; Muir R; Van Snick J; Openshaw PJ
J Immunol; 2009 Dec; 183(11):7006-13. PubMed ID: 19915054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
